Dr. Reddy's Laboratories was founded in 1984 by Dr. K. Anji Reddy and has grown to become one of the largest pharmaceutical companies in India, producing both active pharmaceutical ingredients and finished dosage forms to treat diseases like ulcers, infections, and cardiovascular issues while conducting research on new drug candidates and marketing products globally. The company aims to accelerate access to affordable medicines while maintaining high standards for quality, ethics, and social responsibility.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Dear Students
We can help you to write total dissertation/project report.
Our 9 step method of project writing:-
Step 1) Helping you in Selection of topic.
Step 2) Group discussion / conference call with in team of professors.
Step 3) Helping you in Preparation of Synopsis/ proposal & sent to project guide
Cipla ppt presentation By Ajit R. KulkarniAjit Kulkarni
It consist of History of pharmaceutical industry, company history, prominent companies in market, SWOT analysis, Findings , Learning , Growth rate , Organisational Structure , Ownership Pattern etc.
A Case Study Presentation on "Dr. Reddie's Laboratories"
Done By,
1) Lekha Prasad
2) Lekshmi Vijayakumar
3) Jubin Varghese
4) Joel Sabu
5) Jyothi Vijayan
Students of 2015-2017 MBA Batch MACFAST College Thiruvalla, Kerala
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Dear Students
We can help you to write total dissertation/project report.
Our 9 step method of project writing:-
Step 1) Helping you in Selection of topic.
Step 2) Group discussion / conference call with in team of professors.
Step 3) Helping you in Preparation of Synopsis/ proposal & sent to project guide
Cipla ppt presentation By Ajit R. KulkarniAjit Kulkarni
It consist of History of pharmaceutical industry, company history, prominent companies in market, SWOT analysis, Findings , Learning , Growth rate , Organisational Structure , Ownership Pattern etc.
A Case Study Presentation on "Dr. Reddie's Laboratories"
Done By,
1) Lekha Prasad
2) Lekshmi Vijayakumar
3) Jubin Varghese
4) Joel Sabu
5) Jyothi Vijayan
Students of 2015-2017 MBA Batch MACFAST College Thiruvalla, Kerala
Pharma contract manufacturing companies in india AditiMehra14
Want the best Pharma Contract Manufacturing Company? Find List of top pharmaceutical contract manufacturing companies in India at PharmaAdda. Visit http://www.pharmaadda.in/pharma-contract-manufacturing-companies-in-india
Pharma third party manufacturing companies in Baddi | PharmaaddaAditiMehra14
Looking for the best Pharma third Party Manufacturing Companies in Baddi then visit this blog and get information about contract manufacturing in Baddi. http://www.pharmaadda.in/pharma-third-party-manufacturing-companies-in-baddi
Top generic pharma companies in india pptAditiMehra14
I have provided the analyzed list of Top Generic Pharma Companies in India. Check blog and choose right generic pharma companies franchise for PCD business. For more information visit http://www.pharmaadda.in/top-generic-pharma-companies-in-india
Top 10 pharma companies in haridwar | PharmaaddaAditiMehra14
Best pharma companies in haridware is hard to find. Visit Pharmaadda Blog & Find the list of Top 10 pharmaceutical medicine firms in haridware. For more information visit http://www.pharmaadda.in/top-10-pharma-companies-in-haridwar
List of pharma companies in Dehradun | PharmaaddaAditiMehra14
Mentioned above is the List Of Pharma Companies in Dehradun. Invest in these companies to enhance your business growth. For More details visit the blog. http://www.pharmaadda.in/list-of-pharma-companies-in-dehradun
Top pharma tablets manufacturer in india pptAditiMehra14
Listed companies are the best and Top Pharma Tablets Manufacturer in India. Visit the blog for detailed information about Tablet manufacturing companies. Visit http://www.pharmaadda.in/top-pharma-tablets-manufacturer-in-india
Hi Friends
This is supa bouy
I am a mentor, Friend for all Management Aspirants, Any query related to anything in Management, Do write me @ supabuoy@gmail.com.
I will try to assist the best way I can.
Cheers to lyf…!!!
Supa Bouy
Hi Friends
This is supa bouy
I am a mentor, Friend for all Management Aspirants, Any query related to anything in Management, Do write me @ supabuoy@gmail.com.
I will try to assist the best way I can.
Cheers to lyf…!!!
Supa Bouy
In our blog of Pharmaadda we brings you the Top and best Pharma Manufacturers in Baddi which also provide Contact Manufacturing of medicines, Pharma franchise and Third Party Manufacturing. Hoping the Information granted in our blog is useful for the readers.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
5. Dr. Reddy was an Indian entrepreneur in the
pharmaceutical industry, the founder-chairman of Dr.
Reddy's Laboratories, which he established in 1984, and
chairman of Dr Reddy's Foundation (DRF), the corporate
social responsibility arm of the group, established 1996.The
Government of India, honoured him with the Padma Shri in
2001 and followed it up, later, with the Padmabhushan, for
his contribution to the Indian Pharmaceutical industry. He
was a member of the Indian Prime Minister's Council on
Trade and Industry.
6. • Reddy after graduating from the local high school,
went on to get his first Bachelor of science degree
from Andhra Christian College or A.C. College at
Guntur in 1958. Thereafter he, did his BSc-Tech in
Pharmaceuticals and Fine chemicals from UDCT,
Mumbai followed by a PhD in chemical
engineering from the National Chemical
Laboratory, Pune in 1969.
7.
8. COMPANY BACKGROUND
• Dr.Reddy’s Laboratories Ltd founded in 1984 by
Dr k.Angi Reddy has become India’s second
biggest pharmaceutical company and its
headquartered is in Hyderabad.
• It produces and sells active pharmaceutical
ingredients , finished dosages and biologics.
• It manufactures ulcer medicines, antibiotics, pain
relievers, antidepressants and cardiovascular
drugs.
9. • ON 11April 2001, Dr Reddy’s became the first
pharmaceutical company from Asia Pacific to be
listed on Newyork stock exchange.
• The company carries out research and
development in diabetes, cancer, cardiovascular
diseases and bacterial infections.
• The company has over 120 medications and 60
active pharmaceutical ingredients for drug
manufacture.
10. • Dr Reddy’s market its product in approximately
100 countries , focusing on Europe, India,US and
Russia.
• The company employed over 8255 personnel,
• In 1997 it became the first Indian company to
out-license an original molecule (DRF 2593).
• Its revenue for 2006 - 2007 amounted to $ 1.5
billion, an increase of 24.3% of the previous year
. Its net income amounts to $ 216 million.
11. Company history
• Dr. Reddy's originally launched in 1984 producing
active pharmaceutical ingredients. In 1986,
Reddy's started operations on branded
formulations. Within a year Reddy's had launched
Norilet, the company's first recognized brand in
India. Soon, Dr. Reddy's obtained another success
with Omez, its branded omeprazole – ulcer and
reflux oesophagitis medication – launched at half
the price of other brands on the Indian market at
that time.
12. • Within a year, Reddy's became the first Indian
company to export the active ingredients for
pharmaceuticals to Europe. In 1987, Reddy's
started to transform itself from a supplier of
pharmaceutical ingredients to other
manufacturers into a manufacturer of
pharmaceutical products.
13. Dr.Reddy's began as a supplier to Indian drug manufacturers,
but it soon started exporting to other less-regulated markets
that had the advantage of not having to spend time and
money on a manufacturing plant that would gain approval
from a drug licensing body such as the U.S. Food and Drug
Administration (FDA). By the early 1990s, the expanded scale
and profitability from these unregulated markets enabled the
company to begin focusing on getting approval from drug
regulators for their formulations and bulk drug manufacturing
plants in more-developed economies.
14. Baceuticalngredients in India and seven FDA-inspected and ISO 9001
(quality) and ISO 14001 (environmental management) certified plants
m In 2010, the family-controlled Dr Reddy's denied
that it was in talks to sell its generics business in
India to US pharmaceutical giant Pfizer, which had
been suing the company for alleged patent
infringement after Dr Reddy's announced that it
intended to produce a generic version of
atorvastatin, marketed by Pfizer as Lipitor, an anti-
cholesterol medication. Reddy's was already linked
to UK pharmaceuticals multinational Glaxo
Smithkline.
15. In other European countries
• Apart from subsidiaries in Germany and UK ,
Dr.Reddy’s has agreements in following
European countries.
• DENMARK
• IRELAND
• NETHERLANDS
16. Factors for success
• Controlling the entire value chain
• Implementations of efficient new product
development processes
• High standard of corporate governance
17. Implementations of efficient new
product development processes
• Targeting the streamlining of new product
development process, Dr. Reddy’s implemented
project ‘racha’ using Microsoft accelerator for six
sigma. This is helping the company in taking key
decisions to launch the right products in the
market at the appropriate time.
18. High standard of corporate
governance
• Dr.Reddy’s adherence to high standard
of corporate governance and ethical
business practices has been a key factor
to its success. The mutual trust has
ensured greater success for the company.
19. Future plans
• Having acquired Betapharm, one of the fastest
growing generic companies in Germany over the
past 5 years, Dr.Reddy’s aims at leveraging this
strategic investment to evolve into a mid-sized
global pharmaceutical company. Dr.Reddy’s aims
to increase its revenue substantially and
improve its operating margin.
20. Dr. Reddy's starts clinical trials for CD
TNN Feb 8, 2005, 12.43am IST
• HYDERABAD: Dr Reddy's Laboratories has initiated
Phase I clinical trials for its cardiovascular drug
candidate RUS 3108. They are being conducted in
Belfast, Ireland. The phase I trials will explore the
safety and pharmacokinetic profiles of this drug
candidate in humans.
• This is the first time the company is testing a drug in
Europe. RUS 3108 is being developed for the
treatment of atherosclerosis, the major cause of heart
attacks and strokes. There are currently no drugs that
directly treat atherosclerosis.
21. • According to a company statement, the drug
represents a new approach to the treatment of
atherosclerosis. The RUS 3108 works by
affecting multiple pathways involved in the
disease like inflammation, proliferation and
thrombosis by inducing a protein called
perlecan.
• Company scientists have determined that
regulating the expression of perlecan can
provide direct protection against the disease.
22. • Uday Saxena, chief scientific officer of Dr Reddy's
said, "RUS 3108 represents a unique approach
for treatment of cardiovascular diseases, a
growing unmet medical need worldwide."
• Dr Reddy's conducts its drug discovery research
in Hyderabad and Atlanta and has discovery
programmes in the areas of diabetes,
cardiovascular, anti-infectives, inflammation and
cancer. The company currently has six new
chemical entities at various stages of clinical
development
23. Clinical Research Associate Jobs in Dr.
Reddy's
Internal : QA, Pharmacovigilence,
Medical writing, Medico Marketing, Data Management,,
Quality Check, Medical, Clinical Research Associate,
Regulatory, Formulation Development and Medico-
marketing teams
External : Site Investigators, CRO
24. job as QUALITY ASSURANCE
• EXPERIENCE: 4-8 years
• EDUCATION: M.SC./B.SC
Experience in handling IPQA/ Validation and
training activities in quality assurance
department of a pharnaceutical plant(OSD,
Ointment/ Injectables).
25. Our Purpose
WE ACCELERATE ACCESS TO AFFORDABLE AND
INNOVATIVE MEDICINES
26.
27. TOP RANKING IN INDIA
• A vast range of pharmaceutical products are offered
by Dr. Reddy's Labs. It has 60 APIs and 190
medications to treat various kinds of ailments. It is
now India's third largest pharmaceutical company in
terms of market capitalisation, which was valued at Rs.
56,638.13 crore on 15 June 2015. Its products and
services may be categorised as below:
• Generic Formulations
• Active Ingredients
• Pharmaceutical Services
• Biosimilars
• Propriety Product
28. Laboratories Aims
at making the lives of the individuals healthier and happier.
This company is one of the most popular pharmaceutical
companies with base in more than 100 countries. The
medicines of Dr. Reddy's Laboratories Limited are easily
available all across the globe.
Dr. Reddy's Pharmaceutical Company is very much
customer friendly. It takes care of the fact that maximum
people get benefited by the products of this
pharmaceutical company. It commercialized various
treatments so as to provide high tech treatment to the
masses. It tries to meet the medical needs of the people.
29. Though Dr. Reddy's Laboratories is located in various parts
of the world, it has its headquarters in India. This global
pharmaceutical company can be found over 100 countries.
The subsidiaries of this company are found at various
countries like US, Germany, UK, Russia and Brazil. 16
countries have the representative offices of Dr. Reddy's
Laboratories Limited. 21 countries have third party
distribution. It is one of the prestigious companies to be
listed in NYSE.
30. It is because of the best quality products and wide reach of
its medicines that it gives a tough competition to other
pharmaceutical companies. It has already left a mark in the
global pharmaceutical market.
Dr. Reddy's Pharmaceutical Company has some set values
that make it stand out among all pharmaceutical
companies. These include:
Quality
Harmony and social responsibility
Respect for the individual
Collaboration and team work
Innovation and continuous learning
31. CONTACT
• Contact Details of Dr. Reddy's Laboratories
• Corporate Office
• Dr. Reddy's Laboratories Ltd.
• Greenlands, Ameerpet,
• Hyderabad 500 016, INDIA
• Tel: +91-40-23731946-50
• Fax: +91-40-23731955
• Visit: www.drreddys.com
32. Dr Reddy's Zoloft generic case
dismissed in USA
• India-headquartered Dr Reddy's Laboratories says that a
District Court for the state of New Jersey, USA, has declined
to hear the company's suit seeking a judgement that would
allow it to market a generic version of Pfizer's
antidepressant Zoloft (sertraline).
• Dr Reddy's filed an application for approval of the
compound with the US Food and Drug Administration in
25mg, 50mg and 100mg tablet forms, and was seeking a
decision on whether its generic version infringed Pfizer's
branded product after the latter firm failed to lodge a suit
against it within the 45-day period granted under current
regulations.
33. • The case was dismissed on the basis that Pfizer
required more time to examine if an
infringement had taken place. Dr Reddy's
responded by saying that it intended to provide
Pfizer with whatever information it needed and,
if necessary, renew its suit thereafter.
34. Dr. Reddy’s statement on the receipt of Warning Letter
from US FDA
Dr. Reddy’s Laboratories ( BSE: 500124 / NSE: DRREDDY /
NYSE: RDY ) today issued a statement acknowledging that it
has received a warning letter issued by the US FDA dated
November 05, 2015 relating to its API manufacturing
facilities at Srikakulam, Andhra Pradesh and Miryalaguda,
Telangana, as well as Oncology Formulation manufacturing
facility at duvvada, Visakhapatnam, Andhra Pradesh. This
action follows the earlier inspections of these sites by the
agency in November 2014, January 2015 and February 2015
respectively.
35. • Dr. Reddy’s CEO, G V Prasad commented “We take
quality and compliance matters seriously and stand by
our commitment to fully comply with the cGMP quality
standards across all of our facilities We will respond
comprehensive plan to address these observations
within the stipulated time-frame of 15 days. We will
continue to actively engage with the agency to resolve
these issues and we have also embarked on an initiative
to revamp our quality systems and processes, as an
organization - wide priority.
36. Employee Reviews
“ Good Place to Work ”
“Good company, growth depends on department head ”
“Great Place to learn the business nuances of Pharma at the
start of career.... ”
Amazing opportunities but highly challenging ”
“Quality assurance ”